PHS external guidance addendum: for UKHSA 'Guidance on the use of antiviral agents for the treatment and prophylaxis of seasonal influenza'
Version 1
- Published
- 04 February 2022 (Latest release)
- Type
- Guidance
- Conditions and diseases
This UKHSA guidance has been approved for use in Scotland. The guidance should be used in conjunction with this PHS addendum.
The UKHSA guidance on use of antiviral agents for the treatment and prophylaxis of influenza covers:
- definitions
- treatment of suspected or confirmed influenza
- post-exposure prophylaxis supply of zanamivir acqueous solution
- use of anti-virals in pregnancy, breastfeeding, hepatic or renal dysfunction
General enquiries
If you have an enquiry relating to this publication, please contact phs.flu@phs.scot.
Media enquiries
If you have a media enquiry relating to this publication, please contact the Communications and Engagement team.
Requesting other formats and reporting issues
If you require publications or documents in other formats, please email phs.otherformats@phs.scot.
To report any issues with a publication, please email phs.generalpublications@phs.scot.